Stefanie Heynck
Weatherford College(US)Cancer Research Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms, Computational Drug Discovery Methods, Lung Cancer Research Studies, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer(2012)1,405 cited
- → Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer(2010)821 cited
- → Telomerase activation by genomic rearrangements in high-risk neuroblastoma(2015)599 cited
- → PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR(2009)492 cited
- → Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer(2011)472 cited
- → Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions(2009)262 cited
- → Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer(2009)255 cited
- → Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation(2010)218 cited
- → ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors(2011)187 cited
- → A framework for identification of actionable cancer genome dependencies in small cell lung cancer(2012)181 cited